IFNA1 and cancer: Tumor growth inhibition after injection of short short-term expression vectors carrying IFNα has been obtained in different animal tumor models [19–21] but we have established an aggressive tumor model that could not be subverted by IFNα reflecting the clinical response in most of the cancer patients treated with IFNα.